| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fece74aa8c0cb73d997c194165159cc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate |
2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee9802a5010f89f3df8c3838e7129fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be0365371bc454ff7a621f0a0db2382f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b7f24dfb1e7734b59689e69649b905
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2ad33b11d24a1389b6c7d2eb4343d21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53418c9e80c12d18f559533636fde823 |
| publicationDate |
2019-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-2018150-A3 |
| titleOfInvention |
Pharmaceutical compositions for immediate drug release |
| abstract |
Disclosed are pharmaceutical compositions for immediate release of a drug comprising a metastable form of a pharmaceutically active agent and / or a pharmaceutically active agent in a form at a higher dissolution rate when administered on an empty stomach than after a meal, and further comprising an ionic polymer that serves to balance the dissolution rate difference a pharmaceutically active substance when choosing a different solid form and / or when administered on an empty stomach or after a meal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020225413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022251620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022532540-A |
| priorityDate |
2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |